MedPath

An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research

Not yet recruiting
Conditions
Schizophrenia
Registration Number
NCT05870722
Lead Sponsor
Power Life Sciences Inc.
Brief Summary

Historically, research participation has been biased toward certain demographics. However, there is a shortage of studies that delve into the underlying factors that influence patient participation, both positively and negatively.

Several people will be invited to enroll in this study so that it may collect a variety of data about schizophrenia clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

The data collected from this study will be analyzed and used to improve the experiences of future schizophrenia patients who are recruited for medical trials.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patient has self-identified as planning to enroll in a clinical trial
  • Patient has been diagnosed with schizophrenia
  • Patient is a minimum of 18 years or older
Exclusion Criteria
  • Patient does not understand, sign, and return consent form
  • Inability to perform regular electronic reporting
  • Patient is pregnant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of patients who decide to participate in a schizophrenia research3 months
Rate of patients who remain in schizophrenia clinical trial to trial completion12 month
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath